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Abstract: PZP and GnRH immunocontraceptive vaccines were each tested in white-tailed deer
(Odocoileus virginianus) . Vaccination with PZP produced reversible infertility lasting 1 to 4 years.
The first two years of active immunization resulted in an 89% reduction in fawning. Reduction in
fawning for the 7-year study containing 4 years of no boosting was 72%. PZP immunization
resulted in multi-estrus behavior, with contracepted deer returning to estrus up to 7 times. A five
year study of GnRH immunization was conducted in both male and female deer. Treatment of
does led to reduced fawning rates, reduced estrus behavior and reduced concentrations of
progesterone. During active immunization GnRH does bred to untreated bucks had an 88%
reduction in fawning caused by either immunocontraception or immunocontragestion. Reduction
in fawning for the 5 year study containing 2 years of no boosting was 74%. The vaccine effect was
reversible and directly related to the antibody titer. Infertility lasted up to two years without
boosting. GnRH immunized bucks had no interest in sexual activity when paired with control
females. Depending on the immunization schedule, antlers either dropped early or remained in
velvet.
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The zona pellucida (ZP) is an acellular
glycoprotein
layer
surrounding
the
mammalian oocyte (egg). During fertilization,
sperm must bind to zona pellucida receptors
on the outer surface of the oocyte and
penetrate the ZP for conception to take place
(Miller 2000a). Immunization with PZP
inhibits fertilization. Native porcine zona
pellucida (PZP) vaccines have been used to
produce sterilization in horses, burros , deer ,
baboons and other species (Kirpatrick et al.
1990; Garrott et al. 1992; Turner 1996a,
1996b; Miller 1999b ).

Introduction
A growing interest in nonlethal
methods for population control of nuisance or
damaging species of wildlife has fostered
research in reducing fertility of these pest
wildlife species. Fertility may be reduced by
interfering with the fertilization of the egg
(Contraception) or interfering
with the
implantation or development of the fertilized
egg (Contragestion) (Miller et al. 1998).
Reproduction can be blocked at many
sites in the reproductive process (Figure 1).
Two contraceptive vaccines discussed in this
paper are PZP and GnRH.
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but that other pituitary hormones and their
vital non-sexual functions were not impaired.
GnRH contraceptive vaccines have
been evaluated as immunocastration agents in
pets, cattle, sheep, swine and deer ( Ladd et al.
1994; Adams and Adams 1992; Schanbacher
1998; Meloen et al. 1994; Oonk et al. 1998;
and Miller et al. 2000b)
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Recently, in studies with the Norway
rat (Miller et al. 1997a), we found that both
males and females immunized with a GnRH
vaccine were 100% infertile.
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This study was conducted at the Deer
Research Center of The Pennsylvania State
University, University Park, PA. Deer were
kept in a 17 acre wooded enclosure and
provided hay and pellets ad libitum. During
handling, deer were restrained mechanically
and chemically with 0.5 to 1.0 ml of xylazine .

Figure 1.
Mammalian
Reproductive
Endocrinology; showing blocking sites of the
2 immunocontraceptive vaccines ( GnRH and
PZP) presented in this paper.

PZP vaccine
GnRH is a small peptide hormone that
is not naturally immunogenic, but can be
made immunogenic by coupling it to a carrier
such as keyhole limpet hemocyanin (KLH).
GnRH antibodies bind to endogenous GnRH
and prevent the release of FSH and LH (Ferro
et al.1996; Ferro and Stimson 1998).

Deer were immunized with purified
porcine zona pellucida (PZP) which was
prepared by and purchased from Dr. Dunbar
at the Baylor College of Medicine, Houston,
TX. Eleven deer were injected with 1 ml of
PZP vaccine distributed subcutaneously and
intradermally among several sites above the
vertebrae of the back between the scapulae.
The I ml prime dose consisted of 0.5 ml of
saline containing 500 µg of PZP mixed with
0.5 ml of complete Freund's adjuvant (CFA).
The booster doses contained 300 µg PZP in
0.5 ml saline mixed with 0.5 ml of incomplete
Freund's adjuvant (IFA). Eight control deer
were sham injected with saline mixed I: 1 as
above with CFA in the prime dose or IFA in

The reduction or absence of serum
FSH and LH leads to atrophy of the gonads
leading to infertility in both sexes. The
immunoneutralization of GnRH through the
use of GnRH vaccines appears to be highly
specific, and does not appear to affect other
hypothalamic releasing hormones; Awoniyi et
al. (1993) demonstrated
that GnRH
immunized rats failed to release FSH and LH,
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each boost dose .

mixed I: 1 with incomplete Freund's adjuvant
(IFA). Boost injections were given on a
yearly basis depending on the current antibody
titer. Fawning results of the GnRH treated
does were compared to the fawning rates of
sham treated does and fawning of the does
from the herd not involved in the study (Miller
et al. 2000b).

All of the PZP treated deer were
immunized the first year, 8 of 11 were boosted
the second year, and 4 of 9 deer were boosted
the third year. None of the deer were boosted
after the third year. The decision to boost deer
in the 2nd or 3rd years was determined by the
antibody titer. Those deer that appeared to
have a rapidly dropping antibody titer in the
previous year were boosted.

Laboratory studies

In both the PZP and GnRH studies,
GnRH Vaccine

jugular blood samples were taken immediately
before the prime injection and each boost and
several times after the vaccinations.
Following clotting, samples were centrifuged
at 1000 x g. Serum was harvested and
samples were stored at -20 °es C. for
subsequent
ELISA,
progesterone
or
testosterone assays.

The 10 amino acid GnRH peptide
hormone which is conserved among all
mammals was made immunogenic by
coupling the peptide to KLH, a large protein
containing numerous T cell epitopes. The
GnRH used in this study was synthesized at
Macromolecular Resources, Colorado State
University (Ft. Collins, CO) with the structure
rpEHWSYGLRPGGC-SH]. A glycine was
added at the C terminus as a spacer and a
cysteine was added to ensure consistent
alignment of the peptide to the maleimide
activated protein carrier KLH. The underlined
amino acids represent the native GnRH
molecule (Miller et al. 2000b).

Observations on mating, gestation and
fawning
To determine when the does were in
estrus for both the PZP and GnRH vaccines,
behavioral observations of the bucks toward
the treated does were made by Penn State
University students three times daily from
November 7 through February 12 and then
two times daily until February 28. Behavioral
activity by the buck included sniffing or
pursuit of the female, aggressive guarding, and
mounting and copulation.

In a 5 year study on the effectiveness
of KLH-GnRH vaccine to immunocontracept
deer, eight fertile does and 4 fertile bucks
were injected subcutaneously with one
primary immunization followed later by
booster doses all containing 1 ml of vaccine
distributed among several sites at the center of
the back between the scapulae. All deer
received a prime dose containing 500 µg of
KLH-GnRH in saline mixed I: I with
complete Freund's adjuvant (CFA) and
approximately one month later were given a
boost containing 300 µg of KLH-GnRH

Trans-rectal ultrasound was performed
in late January or early February, and
abdominal palpation was performed in late
March or early April. Blood was drawn the
day of the ultrasound and tested for
progesterone concentration.
From May through August, does were

62

observed daily for evidence of fawning.
Observations on behavioral estrus were used
to estimate the date of conception. Ultrasound
observations were used to confirm that does
were in the first trimester of gestation.
Abdominal palpation was used to confirm that
does were in the last trimester of gestation.

average for each control doe during the
breeding period lasting 44 days. During the
first three years of active immunization, PZP
treated does were observed to have one to four
sexual encounters per doe (mean =3.6), and
remain sexually active over 98 days. Several
does exhibited sexual activity in January and
February. For all 6 years, including years when
fertility was regained by some of the does, the
mean number of estrus events in the PZP
treated deer was 2.4 . One doe was observed
with 7 cycles of sexual activity, with the last
observed activity occurring on March 4. This
doe was sexually active for 150 days but
remained infertile.

PZP results
Fawning
During the first 3 years, when there
was active immunization, 11 treated deer
produced 6 fawns, compared with 56 fawns
from the same number of control does, or an
89% reduction in fawning (P < 0.01). For all
7 years (Table 1), including 4 years when deer
were not boosted, 25 fawns were born to the
PZP treated does compared with 103 fawns
born to the same number of control does, or a
72% reduction in fawning (P < 0.01) . The
sham injected does had a normal fawning rate
similar to the control herd (P > 0.05).

Progesterone levels
During the normal breeding season of
October to December, control deer had serum
progesterone concentrations of ~4.0 ng/ml at
some time during each month representing
ovulation.
There appeared to be some
synchronization of the estrus activity and
elevated progesterone levels in the control herd .
Progesterone concentrations of ~4 ng/ml in late
January to early February generally correlated
with fawning in the control deer. The 4 .0 ng/ml
progesterone in the PZP did not correlate with
pregnancy since the PZP antibody could protect
the ovulated egg from sperm penetration .

The length of time that the deer
remained infertile after they were given a
vaccine boost ranged from 1 to 4 years. There
was a direct correlation between reduced
fawning and antibody titer. As antibody titers
dropped and deer regained fertility most does
had only l fawn, which was born at late as
August or September. As the deer regained
fertility they could be reboosted and the
infertility could last for several years after the
boost.

Ultrasound and palpation
Ultrasound has been shown to be an
excellent predictor of early pregnancy
In
control animals and the PZP treated does, a
positive ultrasound observation in late January
or early February, and a positive abdominal
palpation in April or May were predictive of
fawning.

Behavioral observations
Most control deer in the study were
bred at the first observed estrus, and breeding
was completed during the month of November.
One or two estrus events were observed on
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Table 1. Fawning data of the PZP treated deer as compared to the Sham controls and the breeding Herd
at The Pennsyvania State University, University Park, PA.
Yearly

Cumulative

Fawns/Does

Average

Average

Year

Treatment

92-93

Primed & Boosted

4/11

.36

.36

93-94

Boosted

1/11

.09

.23

94-95

4/9 Boosted

1/9

.11

.19

95-96

None Boosted

3/9

.33

.23

96-97

None Boosted

7/9

.78

.33

97-98

None Boosted

9/8

1.13

.44

98-99

None Boosted

8/7

1.14

.52

Breeding herd

156/90

1.73

Sham controls

1.84

PZP treated

.52
A reduction in fawns of 89% was achieved during active immunization ,
and a 72 % reduction in fawns was seen over seven years including four
years without boosting.

Of the four additional does given GnRH
treatment in the third year, one fawn was born
during the first year. With the additional group
of does added there were 6 fawns/22 doe years
(0.27 fawns/doe/year) as compared with 40
fawns/22 doe years (1.8 fawns/doe/year) in the
control group . This
represents an 88%
reduction ( P<0 .01) in fawning in the GnRH
group compared with the controls. The average
of 1.83 fawns/doe/year among the control does
in the study is representative of the normal
breeding herd average at PSU . Fawns born to
the GnRH treated deer appeared healthy and
normal.

GnRH results
Female deer
Fawning Data. A reduction in fawns of
88% was achieved during active immunization,
and a 74% reduction in fawns was observed
over five years including two years without
boosting (Table 2).
Five fawns were born to the 4 does
during the 4 years, or 5 fawns/14 doe years (doe
years the number of does times the number
years tested), compared to 25 fawns/14 doe
years in the control deer during this same period
of time.
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Table 2. Fawning data of the GnRH treated deer as compared to the Sham controls and the breeding
herd at The Pennsyvania State University, University Park, PA
Year

Treatment

94-95

Primed & boosted

3/4

95-96

Primed & boosted

0/6

96-97

Boosted

1/8

97-98

No boost

3/8

98-99

No boost

9/9

Fawns/Does

Breeding herd

156/90 (x=l.7)

Sham controls

35/19 (x= 1.8)

GnRH treated

16/35 (x=.46)

A reduction in fawns of 88% was achieved during active immunization,
and a 74% reduction in fawns was seen over five years including two years
without boosting .

Under
Behavioral observations.
normal situation, deer are asexual for the
majority of the year. The short day lengths of
the autumn tum on the sexual activity for the
short breeding season. Some of the GnRH
treated deer never develop this seasonal sexual
activity and remained asexual throughout the
breeding season . Although progesterone data
indicated that the does were not cycling, there is
some activity from the bucks, ranging from
sniffing the does to short pursuits of bucks
chasing does. The limited amount of estrus
activity in the GnRH treated does was observed
over 30 days. The observed estrus events for
the control does were typically 1 or 2 per doe
over a total period of 44 days.

Male deer
Control bucks in our study had serum
testosterone concentrations of less than 100
ng/100 ml late summer and early fall and
developed
normal breeding
levels of
testosterone (350 to > 400 ng/100 ml) in
October. Peak breeding activity occurred in
November when bucks were introduced to
does. Antlers grew slowly early in the summer
but rapid growth ensued in August and
September. Antlers remained in velvet until
September at which time the velvet was rubbed
off on nearby trees. Antlers dropped off in
March of the following year. The bucks in the
GnRH group were treated the first year with a
prime dose in September and boosts in
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October. They lost their already hardened
antlers two weeks after the second boost
(between October 20 to 28). Their testes were
less then one half the size of normal bucks, and
they did not develop the prominent neck
musculature normally observed in the autumn
on mature bucks and therefore looked very
much like a doe throughout the breeding
season. Treated bucks were penned with
untreated cycling does but demonstrated little
sexual interest in the does. Serum testosterone
levels for the GnRH-treated bucks ranged from
11-74 ng/100 ml throughout the breeding
season, which were in the range of levels
during the non-breeding period.

1 buck remained infertile with regressed
testicles (even though the antibody titer had
dropped) until he died several years later.
Discussion
Both the PZP and GnRH vaccines have
advantages and disadvantages. Both vaccines
change the behavior of the deer in reproductive
season. The PZP vaccine induced infertility in
does is associated with increased sexual activity
for an extended period, as evidenced by an
average increase in the number of estrous
cycles observed per doe. Although the multiple
estrous cycles observed with PZP-treated does
have been reported by others (Turner et al.
1992), the present study clearly demonstrates
that if the PZP antibody titer drops to an
unprotecting level late in the breeding season,
conception may occur resulting in fawns born
in August or September, which places them at
considerable risk for winter survival. The
increased duration of the rutting season may
increase deer-car collisions because of the
restlessness of the herd. In our study, the
control herd majority had become pregnant in
44 days, but the PZP treated deer were still
cycling after this period. There is little or no
observable difference in the appearance of the
PZP treated deer as compared to the control
does.

In the second year, three of the bucks
were boosted with the KLH-GnRH vaccine in
July and August. The fourth buck died before
the start of the second year of research. The
anti-GnRH titers peaked in September. The
testosterone of these bucks remained less than
30 ng/100 ml throughout the breeding season.
In contrast to the first year, the antlers remained
in velvet throughout the fall. The antlers never
cleaved normally at the base of the pedicel, but
instead broke off 1 to 4 inches above the
pedicel between January 10 and February 13.
This breakage was likely a result of freezing
temperatures killing the unhardened antler,
thereby resulting in reduced antler strength.

The does treated with the GnRH
vaccine have a reduced level of estrus activity.
The GnRH treated bucks have little sexual
interest in the control does, and the effects of
reduced testosterone in the bucks either causes
the antlers to drop off in the fall the year of
treatment or remain in velvet in the succeeding
years.

The sexual responses of the bucks were
directly related to the anti-GnRH titers
throughout the three years . When GnRH
treated bucks were put in the same pen with
control cycling females they demonstrated no
sexual interest in the does that were in estrous.
At the same time the GnRH treated bucks were
casually eating next to the doe in estrus, the
fertile buck in the next paddock was trying to
break down the fence. Three out of the four
bucks returned to fertility in 2 years; however,

The GnRH vaccine has potential as a
management technique that could control
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population size as well as reduce deer
movements during rutting season, thereby
reducing deer/car collisions. Additionally, the
vaccine could reduce the aggressiveness of a
"pet buck" in a park setting during the fall
rutting season.

74%. The GnRH conjugate produced high
antibody titers resulting in infertility for up to
two years without boosting. It appears that this
vaccine is reversible; that is, when the antibody
titer drops, fertility is restored. Furthermore,
the deer could be boosted again causing the
deer to again become infertile. There was little
difference in the observed behavioral effects
between the GnRH treated does and the control
does. GnRH treated bucks, on the other hand,
lost most sexual interest in the does coming
into estrus. Early antler loss and the absence of
antler hardening may be considered negative
side effects of treating bucks.

Although both PZP and GnRH
demonstrate
potential as contraceptives,
improved delivery methods still need more
research (Miller 1997 b; Miller et al. 1999a) In
addition
to the immunocontraceptive
technology, research in other methods of
interrupting reproduction to control population
of various pest species need more research
(Miller and Fagerstone 2000)

Literature cited
Adams, T. E., and B. M. Adams. 1992.
Feedlot performance of steers and bulls
actively
immunized
against
gonadotropin-releasing
hormone .
Journal of Animal Science. 70:691-698 .

Conclusion
Both vaccines are effective in reducing
the fertility of white-tailed deer. In PZP
immunocontracepted deer, fertility was reduced
as much as 89% during active immunization,
and for the entire 7-year study, with 4 years of
no immunization, was reduced by 72%. PZP
immunization stimulates high antibody titers
that can reduce fertility for one to four years
without boosting. Thereafter, as anti-PZP titers
declined, doe fertility was restored, but at a
reduced fawning rate . Previously infertile does
that regained fertility were again made infertile
by a single boost before the next breeding
season. The prolonged contraceptive effects of
the PZP vaccine are desirable aspects as an
agent for deer population control. However,
these benefits should be weighed against the
extended breeding season and late fawning
associated with its use .

Awoniyi, C. A., M. S. Reece, B. S. Hurst, K. A.
Faber , V. Chandrashekar, and W. D.
Schlaff. 1993. Maintenance of sexual
function with testosterone in the
gonadotropin-releasing
hormone
immunized hypogonadotropic infertile
male rat. Biology of Reproduction
49 : 1170-76 .
Ferro, V. A., J. E. O' Grady, J. Notman, and W.
H. Stimson . 1996. An investigation
into the immunogenicity of a GnRH
analogue in male rats: a comparison of
the toxicity of various adjuvants used in
conjunction
with GnRH-glycys.
Vaccine 14:451-57 .

The GnRH vaccine is effective during
active immunization in reducing fawning rates
by 88% . After 2 years of no immunization the
overall reduction in fawning for the 5 years was

Ferro, V . A., and W. H. Stimson. 1998.
Investigation into suitable carrier
molecules for use in an anti-

67

Miller, L. A., B. E . Johns, and D . J. Elias .
1998 .
Immunocontraception as a
wildlife management tool:
Some
perspectives. Wildlife Society Bulletin
26 :237-243 .

gonadotropin
releasing
hormone
vaccine . Vaccine 16: 1095-1102.
Garrott, R. A., D . B . Siniff, J. R. Tester, T. C.
Eagle, and E. D. Plotka . 1992 . A
comparison
of contraceptive
technologies
for feral
horse
management. Wildlife Society Bulletin
20: 318-326.

Miller , L.A., B. E. Johns , D. J. Elias, and G. J.
Killian 1999a . Oral Vaccination of
White-tailed
Deer
U s ing
a
Recombinant Bacillu s Calmette-Guerin
Vaccine Expressing the Borrelliad
burgdorferi Outer Surface Protein A :
Prospects for Immunocontraception.
American Journal of Reproductive
Immunology 41 : 279-285.

Kirkpatrick , J. F ., I. K. M . Liu, J. W. Turner.
1990.
Remotely - de! i vered
irnrnunocontraception in feral horses .
Wildlife Society Bulletin 18: 326-330.
Ladd , A., Y. Y. Tsong, A. M. Walfield , R.
Thau. 1994.
Development of an
antifertility vaccine for pets based on
active immunization against luteinizing
hormone-releasing hormone. Biology
of Reproduction 51: 1076-83.

Miller , L. A., B. E. Johns, and G. J. Killian.
1999. Long term effects of PZP
immunization on reproduction
in
White-tailed deer. Vaccine 18: 568-574
Miller, L. A., B. E. Johns , and G. J. Killian.
2000a. Irnrnunocontraception of whitetailed
deer using
native
and
recombinant zona pellucida vaccines.
Animal Reproduction Science 63: 187195.

Meloen R.H. , J. A. Turkstra , W. C . Lankhof ,
H. Puijk, W . C. Schaaper , W. M. M.
Dijkstra , G. Wensing , and R. B. Oonk.
1994. Efficient immunocastration of
male piglet s by immunoneutralization
of GnRH using a new GnRH-like
peptide. Vaccine 12:741 -6.

Miller, L. A., B. E. Johns , and G. J . Killian .
2000b .
Immunocontraception
of
White-tailed deer with GnRH vaccine.
American Journal of Reproductive
Immunology . 44: In Press .

Miller , L.A., B. E. Johns , D . J. Elias, and K. A.
Crane . 1997a . Comparative efficacy
of two immunocontraceptive vaccines .
Vaccine 15: 1858-1862 .
Miller,

Miller , L. A., and K. A. Fagerstone. 2000.
Induced infertility as a wildlife
management tool. Proceedings of the
Vertebrate Pest Conference . 19: In
Press.

L. A.
1997b.
Delivery of
immunocontraceptive
vaccines for
wildlife management. Pages 49-58 in
T . J. Kreeger , editor. Contraception in
Wildlife Management. USDA/ APHIS
Technical Bulletin No. 1853.

68

Oonk, H. B., J. A. Turkstra, W. Schaaper, M.
M . Erkens, M. H. Schuitemakerde Weerd, J. H. M.Van Nes, A,
Verheijden, and R. H. Meloen. 1998.
New GnRH-like peptide construct to
optimize efficient immunocastration of
male pigs by immunoneutralization of
GnRH. Vaccine 16: 1074-82.
Schanbacher, B. D. 1982. Response of ram
lambs to active immunization against
testosterone and luteinizing hormonereleasing hormone. American Journal
of Physiology 242: 201-205.
Turner , J. W. , I. K. M Liu, J. F. Kirkpatrick
1992.
Remotely
delivered
immunocontraception in captive whitetailed deer.
Journal of Wildlife
Management 56: 154-157 .
Turner, J. W., I. K. M . Liu, J. F. Kirkpatrick .
1996a.
Remotely
delivered
immunocontraception in free-roaming
feral burros (Equus asinus) . Journal of
Reproductive Fertility 107: 31-35.
Turner, J. W., J. K. Kirkpatrick, I. K. M . Liu.
1996b. Effectiveness, reversibility,
and serum antibody titers associated
with immunocontraception in captive
white-tailed deer. Journal of Wildlife
Management 60: 45-51.

69

